EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SMURF2 inhibits autophagic control of Mycobacterium tuberculosis in macrophages

Priscila C Campos, Kathryn C Rahlwes, Victoria A Ektnitphong, Beatriz Rs Dias, Kubra F Naqvi, Samuel Alvarez-Arguedas, Michael U Shiloh

JCI Insight · 2026

DOI: 10.1172/jci.insight.199853 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCI Insight, 2026. Verfasst von Priscila C Campos und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and. Hauptthemen laut MEDLINE: Macrophages, Ubiquitin-Protein Ligases, Autophagy, Mycobacterium tuberculosis. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autophagy is a critical host defense mechanism that restricts intracellular pathogens such as Mycobacterium tuberculosis . A key step in this process is the ubiquitination of M . tuberculosis or M . tuberculosis –associated structures. The E3 ligase Smad-specific E3 ubiquitin protein ligase 1 (SMURF1) catalyzes K48-linked ubiquitination, promoting bacterial clearance. However, the function of its homolog, SMURF2, in host defense remains undefined. Here, we demonstrate that Smurf2 deletion in murine macrophages increases SMURF1 levels, enhances LC3B lipidation, augments K48 ubiquitination of M . tuberculosis –associated structures, and reduces intracellular M . tuberculosis replication. These effects are reversed by Smurf1 deletion, supporting a role for SMURF1 in SMURF2-dependent control of M . tuberculosis . Mice with myeloid-specific Smurf2 deletion exhibit modestly prolonged survival after aerosol M . tuberculosis infection. In human macrophages, SMURF2 knockdown or its pharmacological inhibition with the HECT E3-ligase inhibitor Heclin reduces M . tuberculosis replication. Together, our findings identify SMURF2 as a negative regulator of macrophage control of M . tuberculosis and support further investigation of SMURF2 as a potential target for host-directed therapy in tuberculosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesUbiquitin-Protein LigasesAutophagyMycobacterium tuberculosisTuberculosisAnimalsMiceHumansUbiquitinationMice, Knockout

Stichwörter der Autor:innen

AutophagyImmunologyInfectious diseaseInnate immunityMicrobiologyTuberculosis

Substanzen

Ubiquitin-Protein LigasesSmurf2 protein, mouseSmurf1 protein, mouse

Autor:innen und Institutionen

  • Department of Internal Medicine and.
  • Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • NCI NIH HHS
  • NHLBI NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Campos, P. C., Rahlwes, K. C., Ektnitphong, V. A., Dias, B. R., Naqvi, K. F., Alvarez-Arguedas, S., & Shiloh, M. U. (2026). SMURF2 inhibits autophagic control of Mycobacterium tuberculosis in macrophages. JCI Insight. https://doi.org/10.1172/jci.insight.199853

Vancouver

Campos PC, Rahlwes KC, Ektnitphong VA, Dias BR, Naqvi KF, Alvarez-Arguedas S, et al. SMURF2 inhibits autophagic control of Mycobacterium tuberculosis in macrophages. JCI Insight. 2026. doi:10.1172/jci.insight.199853

BibTeX
@article{Campos2026,
  author = {Campos, Priscila C and Rahlwes, Kathryn C and Ektnitphong, Victoria A and Dias, Beatriz Rs and Naqvi, Kubra F and Alvarez-Arguedas, Samuel and Shiloh, Michael U},
  title = {SMURF2 inhibits autophagic control of Mycobacterium tuberculosis in macrophages},
  journal = {JCI Insight},
  year = {2026},
  doi = {10.1172/jci.insight.199853}
}
Kostenlos starten →